Northwestern's Dr. Douglas Vaughan says most peptide claims rest on cell and animal data, while Dr. Florence Comite warns about use without medical oversight.
Recap by typeshit. Full story at Oprah Daily.
Lincoln Journal Star reports FDA advisors are weighing whether seven unapproved peptides can be used in some compounded prescriptions.
MedPro Group points to an HHS move letting pharmacies compound six peptides that lack FDA approval. Details are in the linked story.
The segment covers a federal draft policy that could open access to some injectable peptides, alongside proposed changes to infant formula nutrients.
The longevity researcher argues the FDA system has grown too slow and costly, saying it favors big drugmakers. He offers this as the reason reform efforts emerged.
This week's MPR episode touches on retatrutide's weight loss data alongside an Ultomiris approval and a Fast Tracked Alzheimer vaccine.
The National Pharmacy Association reports fake obesity cases, and the GPhC regulator says pharmacists who fail to verify weight will face sanctions.
Loading…